Report Detail
Europe Flu Vaccine Market Report 2019
- RnM3864227 |
- 16 January, 2020 |
- Global |
- 106 Pages |
- XYZResearch |
- Pharma & Healthcare
In this report, in the last several years, the EMEA (Europe, Middle East and Africa) market of Flu Vaccine developed rapidly, with an average growth rate of 7.50%. In 2016, EMEA (Europe, Middle East and Africa) Revenue of Flu Vaccine is nearly 750 M USD; the actual sales are about 77 M Doses.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 was about 43%, and the proportion was in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3years. The most proportion of Flu Vaccine is For Adults and Children over 3years, and the proportion in 2016 was about 75%.
The Europe in the EMEA was the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany was the largest consumption place with the consumption market share of 12%. Following Russia, France was the second largest consumption region, with the proportion of 11%.
Market competition is not intense. CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer and Johnson & Johnson, etc. are the leaders of the industry in the EMEA, with high-end customers in the Flu Vaccine market.
Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Flu Vaccine for these regions, from 2014 to 2026 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain
Europe Flu Vaccine market competition by top manufacturers/players, with Flu Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
...
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Flu Vaccine for each application, including
For Children (6 months to 3 years)
For Adults and Children over 3 years
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Flu Vaccine Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 Whole Virus Vaccines Market Performance (Volume)
- 2.1.2 Split Virus Vaccines Market Performance (Volume)
- 2.1.3 Subunit Vaccines Market Performance (Volume)
- 2.1.4 Live Attenuated Virus Vaccines Market Performance (Volume)
- 2.2 Overall Market Performance(Value)
- 2.2.1 Whole Virus Vaccines Market Performance (Value)
- 2.2.2 Split Virus Vaccines Market Performance (Value)
- 2.2.3 Subunit Vaccines Market Performance (Value)
- 2.2.4 Live Attenuated Virus Vaccines Market Performance (Value)
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 For Children (6 months to 3 years) Market Performance (Volume)
- 3.1.2 For Adults and Children over 3 years Market Performance (Volume)
4 Manufacturers Profiles/Analysis
- 4.1 CSL
- 4.1.1 CSL Profiles
- 4.1.2 CSL Product Information
- 4.1.3 CSL Flu Vaccine Business Performance
- 4.1.4 CSL Flu Vaccine Business Development and Market Status
- 4.2 GSK
- 4.2.1 GSK Profiles
- 4.2.2 GSK Product Information
- 4.2.3 GSK Flu Vaccine Business Performance
- 4.2.4 GSK Flu Vaccine Business Development and Market Status
- 4.3 Sanofi Pasteur
- 4.3.1 Sanofi Pasteur Profiles
- 4.3.2 Sanofi Pasteur Product Information
- 4.3.3 Sanofi Pasteur Flu Vaccine Business Performance
- 4.3.4 Sanofi Pasteur Flu Vaccine Business Development and Market Status
- 4.4 Mylan
- 4.4.1 Mylan Profiles
- 4.4.2 Mylan Product Information
- 4.4.3 Mylan Flu Vaccine Business Performance
- 4.4.4 Mylan Flu Vaccine Business Development and Market Status
- 4.5 AstraZeneca
- 4.5.1 AstraZeneca Profiles
- 4.5.2 AstraZeneca Product Information
- 4.5.3 AstraZeneca Flu Vaccine Business Performance
- 4.5.4 AstraZeneca Flu Vaccine Business Development and Market Status
- 4.6 Pfizer
- 4.6.1 Pfizer Profiles
- 4.6.2 Pfizer Product Information
- 4.6.3 Pfizer Flu Vaccine Business Performance
- 4.6.4 Pfizer Flu Vaccine Business Development and Market Status
- 4.7 Johnson & Johnson
- 4.7.1 Johnson & Johnson Profiles
- 4.7.2 Johnson & Johnson Product Information
- 4.7.3 Johnson & Johnson Flu Vaccine Business Performance
- 4.7.4 Johnson & Johnson Flu Vaccine Business Development and Market Status
5 Market Performance for Manufacturers
- 5.1 Europe Flu Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020
- 5.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020
- 5.3 Europe Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 5.4 Europe Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 Germany Market Performance for Manufacturers
- 6.1.1 Germany Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.1.2 Germany Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.1.3 Germany Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.1.4 Germany Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.1.5 Market Concentration
- 6.2 UK Market Performance for Manufacturers
- 6.2.1 UK Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.2.2 UK Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.2.3 UK Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.2.4 UK Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.2.5 Market Concentration
- 6.3 France Market Performance for Manufacturers
- 6.3.1 France Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.3.2 France Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.3.3 France Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.3.4 France Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.3.5 Market Concentration
- 6.4 Russia Market Performance for Manufacturers
- 6.4.1 Russia Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.4.2 Russia Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.4.3 Russia Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.4.4 Russia Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.4.5 Market Concentration
- 6.5 Benelux Market Performance for Manufacturers
- 6.5.1 Benelux Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.5.2 Benelux Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.5.3 Benelux Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.5.4 Benelux Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.5.5 Market Concentration
- 6.6 Italy Market Performance for Manufacturers
- 6.6.1 Italy Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.6.2 Italy Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.6.3 Italy Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.6.4 Italy Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.6.5 Market Concentration
- 6.7 Spain Market Performance for Manufacturers
- 6.7.1 Spain Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.7.2 Spain Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.7.3 Spain Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.7.4 Spain Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.7.5 Market Concentration
- 6.8 Market Performance for Manufacturers
- 6.8.1 Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.8.2 Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.8.3 Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.8.4 Flu Vaccine Gross Margin of Manufacturers 2014-2020
- 6.8.5 Market Concentration
7 Europe Flu Vaccine Market Performance (Sales Point)
- 7.1 Europe Flu Vaccine Sales (K Units) and Market Share by Regions 2014-2020
- 7.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Regions 2014-2020
- 7.3 Europe Flu Vaccine Price (USD/Unit) by Regions 2014-2020
- 7.4 Europe Flu Vaccine Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
- 8.1 Europe Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.2 Germany Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.3 UK Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.4 France Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.5 Russia Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.6 Benelux Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.7 Italy Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.8 Spain Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Distributors
11 Consumer Analysis
- 11.1 For Children (6 months to 3 years) Industry
- 11.2 For Adults and Children over 3 years Industry
12 Market Forecast 2021-2026
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
- 12.1.1 Europe Flu Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
- 12.1.2 Europe Flu Vaccine Sales (K Units) and Growth Rate 2021-2026
- 12.1.3 Germany Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.4 UK Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.5 France Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.6 Russia Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.7 Benelux Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.8 Italy Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.9 Spain Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
- 12.2.1 Overall Market Performance
- 12.2.2 Whole Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2.3 Split Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2.4 Subunit Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2.5 Live Attenuated Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.3 Sales Forecast by Application 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 For Children (6 months to 3 years) Sales and and Growth Rate 2021-2026
- 12.3.3 For Adults and Children over 3 years Sales and and Growth Rate 2021-2026
- 12.4 Price (USD/Unit) and Gross Profit Forecast
- 12.4.1 Europe Flu Vaccine Price (USD/Unit) Trend 2021-2026
- 12.4.2 Europe Flu Vaccine Gross Profit Trend 2021-2026
13 Conclusion
Summary:
Get latest Market Research Reports on Europe Flu Vaccine. Industry analysis & Market Report on Europe Flu Vaccine is a syndicated market report, published as Europe Flu Vaccine Market Report 2019. It is complete Research Study and Industry Analysis of Europe Flu Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
